Results 241 to 250 of about 73,159 (323)

Predicting QT interval prolongation in patients diagnosed with the 2019 novel coronavirus infection. [PDF]

open access: yesAnn Noninvasive Electrocardiol, 2021
Zhao W   +5 more
europepmc   +1 more source

Cardiovascular Safety of VIAN‐c4551, an Antiangiogenic Peptide Derived From Vasoinhibin

open access: yesDrug Development Research, Volume 86, Issue 7, November 2025.
ABSTRACT Vasoinhibin is a potent antiangiogenic protein that blocks the activation of endothelial nitric oxide synthase (eNOS) in response to vascular endothelial growth factor, bradykinin, and acetylcholine (ACh). In this regard, VIAN‐c4551, a new synthetic vasoinhibin analog, has therapeutic potential for targeting angiogenesis in oncology and ...
Miguel A. García‐González   +13 more
wiley   +1 more source

Polymorphic Ventricular Tachycardia with QT Interval Prolongation Due to a Brain Tumor. [PDF]

open access: yesIntern Med, 2021
Nakayama Y   +6 more
europepmc   +1 more source

392 A Prospective Study Evaluating QT Intervals After Antiemetics and Antihistamines in Unfunded Emergent Dialysis With Baseline QT Prolongation [PDF]

open access: bronze, 2014
Lynn P. Roppolo   +6 more
openalex   +1 more source

B‐Type Natriuretic Peptides Levels in Patients With Beta‐Thalassemia Major and Correlations With Biomarkers: A Systematic Review and Meta‐Analysis

open access: yesHealth Science Reports, Volume 8, Issue 11, November 2025.
ABSTRACT Background Patients with beta‐thalassemia major are prone for developing cardiovascular complications. Early identification of patients at risk is important. B‐type natriuretic peptides such as brain natriuretic peptide (BNP) and N‐terminal pro‐BNP (NT‐proBNP) are sensitive indicators of cardiac dysfunction.
Mohamed S. K. Salih   +9 more
wiley   +1 more source

Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation. [PDF]

open access: yesFront Cardiovasc Med, 2022
Lazzerini PE   +19 more
europepmc   +1 more source

Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide.

open access: yesJournal of Clinical Oncology, 2014
G. Roboz   +8 more
semanticscholar   +1 more source

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

open access: yesThe Journal of Clinical Pharmacology, Volume 65, Issue 11, Page 1411-1419, November 2025.
Abstract Fruquintinib is a highly selective oral inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, approved by the US Food and Drug Administration and the European Commission for the treatment of previously treated metastatic colorectal cancer (mCRC), regardless of biomarker status. This study used concentration QT interval (C‐QTc)
Xiaofei Zhou   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy